Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 798 results for "fusion iii"

Ford unveils sleeker self-driving Fusion
CNN Money

Ford unveils sleeker self-driving Fusion

A joy ride with Henry Ford III Ford's self-driving car team has a brand new toy. The company unveiled on Wednesday an updated version of its autonomous car Fusion. The automaker sees the latest iteration as a significant step toward its goal ... CNN Money, 3 weeks ago

4 images for fusion iii

Investing.com, 1 month ago
Special Events, 2 months ago
Investing.com, 3 months ago
Billboard, 4 months ago

Bone Therapeutics Provides Business Update for Q4 2016

Positive efficacy data for the ALLOB® Phase IIA spinal fusion trial Allogeneic platform ALLOB® and osteonecrosis Phase III study main strategic focus Thomas Lienard appointed Chief Executive Officer EUR 2.3 Million in Non-Dilutive Funding ...
 Nasdaq1 day ago BONE THERAPEUTICS : Granted EUR 2.3 Million in Non-Dilutive Funding by the Walloon Region  4 Traders1 week ago Bone Therapeutics Granted EUR 2.3 Million in Non-Dilutive Funding By  BioSpace1 week ago Bone Therapeutics Announces Its Financial Calendar for 2017  BusinessWire.co.uk4 weeks ago
[x]  

Davis Love III faces three months out after snowboarding crash

Davies Love III broke his collarbone while snowboarding Davis Love III has broken his collarbone in three places in a snowboarding accident. Love underwent surgery on Thursday night, with a metal plate and eight screws used to help repair his ...
 Sky Sports1 week ago

Mechanism of membrane fusion induced by vesicular stomatitis virus G protein [Biophysics and Computational Biology]

Irene S. Kim a , 1 , Simon Jenni a , Megan L. Stanifer b , 2 , Eatai Roth c , Sean P. J. Whelan b , Antoine M. van Oijen a , 3 , and Stephen C. Harrison a , d , 4 a Department of Biological Chemistry and Molecular Pharmacology, Harvard ...
 PNAS2 weeks ago

Chevy's Malibu sedan returns for 2017 with gasoline-only and...

All About Cars By G. CHAMBERS WILLIAMS III Chevrolet's popular midsize Malibu sedan returns for 2017 after a major redesign last year that also brought a hybrid version. One of Chevrolet's oldest and most recognized nameplates, the Malibu, ...
 MySanAntonio1 month ago

Novartis announces positive results from phase III ASCEND-4 study of Zykadia to treat patients with ALK+ advanced NSCLC

Novartis announced results from its phase III open-label, randomized, active-controlled, multi-center ASCEND-4 study, which found that patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) treated with ...
 PharmaBiz1 month ago Novartis: Zykadia More Than Doubles Progression-free Survival In ASCEND-4 Study  Quotenet.com1 month ago Novartis announces Zykadia® first-line study results showing 16.6 month progression-free survival in patients with ALK+ advanced NSCLC  PharmaVOICE1 month ago Cure For Cancer: Novartis Drug Zykadia Beats Chemotherapy In Lung Cancer Patients  International Business Times1 month ago
[x]  
EuroInvestor

MGX Minerals drills 120 m of 42% MgO at Driftwood

MGX MINERALS REPORTS PHASE III DRILL RESULTS FROM DRIFTWOOD CREEK MAGNESIUM- UP TO 120 METERS GRADING 42.0% MAGNESIUM OXIDE MGX Minerals Inc. has released assay results from infill and extension drilling at its flagship Driftwood Creek magnesium ...
 Stockwatch1 month ago MGX Minerals Reports Phase III Drill Results from Driftwood Creek Magnesium- Up to 120 Meters Grading 42.0% Magnesium Oxide  TheNewswire.ca1 month ago
[x]  

Excitement fills Campion on Annual's closing day

day of three-day celebrations of Campion School's annual day, over 2000 students from standard III to V actively participated and made the function an enjoyable experience. Cheer and thrill filled the air as the students of the primary wing of ...
 New Delhi Pioneer1 month ago MV International celebrates Annual Day  Daily Excelsior.com1 month ago
ODT Mag

NuVasive to Resume XLIF Procedures in Japan in First Quarter

Japanese regulators give Class III approval to instruments used in XLIF procedure. NuVasive Inc. has received approval from the Japanese Ministry of Health, Labour, and Welfare (MHLW) for instruments used in the eXtreme Lateral Interbody Fusion ...
 ODT Mag2 weeks ago NuVasive Q4, FY2016 prelims beat estimates  MassDevice1 week ago NUVASIVE : to Resume XLIF Procedures in Japan in First Quarter 2017  4 Traders2 weeks ago BRIEF-Nuvasive to resume XLIF procedures in Japan in first quarter 2017 (NUVA)  Business Insider2 weeks ago
[x]  

Loxo Oncology reports positive results from Phase I study of larotrectinib to treat TRK fusion cancers

US-based biopharmaceutical company Loxo Oncology has reported positive results from its Phase I study of larotrectinib (LOXO-101) to treat tropomyosin receptor kinase (TRK) fusion cancers. Larotrectinib has been developed as a potent, orally ...
 Drug Development Technology4 weeks ago CSL Behring Presents New Phase III Analysis of IDELVION for Hemophilia B at the 2016 American Society of Hematology Annual Meeting  Pharmacy Choice4 weeks ago CSL Behring reports positive Phase III PROLONG-9FP trial data of IDELVION to treat haemophilia B  Drug Development Technology1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less